Serine hydroxymethyltransferase 2 (SHMT2) converts serine into glycine and a one-carbon unit bound to tetrahydrofolate, supporting the synthesis of thymidines and purines, thereby promoting tumor growth 68. The gene discussed is SHMT2; the disease is neoplasm.